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English summary 
With a prevalence of around 1 %, epilepsy is one of the most common neural disorders in the world. 
About 30 % of the patients do not achieve satisfactory seizure control by means of conventional 
treatments such as anti-epileptic drugs (AED) and surgery. Electrical stimulation of the vagus nerve 
(VNS) may be an option for treating these refractory patients, however, only about half of the patients 
respond to this treatment and few become totally seizure free. Thus improvements and new methods are 
needed for the treatment of refractory epilepsy. The current work investigated two neural engineering 
methods, which may improve the management of uncontrolled seizures.  
Studies show that VNS initiated prior to or during the early start of seizures may alleviate, shorten or 
even prevent seizures from occurring. In order to realize that kind of treatment, early seizure detection is 
needed. The current study investigated if seizures can be detected early and monitored using neural 
recordings (ENG) from the vagus nerves. Our results show that a specific cardiac-related firing pattern 
could be derived from the vagus-ENG (VENG) recordings in a rat model. These firing patterns changed 
more than 80 s prior to and during seizures, thus indicating that seizure activity may be detected early and 
monitored using the VENG. The detection method may be suitable especially for controlling VNS, as 
stimulation and seizure detection could be performed using the same vagus nerve electrode. However, 
further studies are needed to evaluate if these (pre-)ictal changes are also present in other animal models 
and in humans.  
Seizure inhibition via electrical stimulation may not be exclusively related to the vagus nerve, thus 
stimulation of other neural structures and peripheral nerves have been shown to induce seizure inhibition 
too. We investigated if dorsal epidural spinal cord stimulation (SCS), which is a well-known treatment for 
chronic pain, could be used to modulate seizure susceptibility. Our results showed that 4 Hz SCS induced 
a clear pro-convulsive effect, whereas 54 Hz SCS caused a statistically non-significant trend towards an 
anti-convulsive effect. Thus, seizure susceptibility may clearly be modulated by means of SCS, however, 
further research is needed to evaluate if stimulation parameters can be optimized to produce clinical 
relevant seizure inhibition.  
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Danish summary 
Med en prævalens på omkring 1 % er epilepsi en af de mest udbredte neurologiske lidelser i verden. 
Omkring 30 % af patienterne opnår ikke en tilfredsstillende anfalds kontrol via konventionelle 
behandlinger såsom anti-epileptisk medicin eller operation. Elektrisk stimulation af vagus nerven (VNS) 
kan være en behandlingsmulighed for disse svært-behandlbare patienter, men kun omkring halvdelen har 
gavn af behandlingen og kun få bliver helt anfaldsfri. Så der er stadig et behov for forbedringer og ny 
metoder i behandlingen af svært-behandelbar epilepsi. Dette arbejde undersøger to medikotekniske 
metoder som kan forbedre håndteringen af ukontrollerbare anfald.  
Studier  viser at hvis VNS startes før eller i starten af anfald kan dette lindre, afkorte eller helt modvirke 
at anfaldene opstår. For at muliggøre denne behandlingsform er det nødvendigt at anfald detekteres 
tidligt. Dette studie undersøgte om anfald kan detekteres tidligt og monitoreres ud fra målinger fra vagus 
nerven (VENG). Vores resultater fra en rotte model viser at et specielt hjerte relateret aktivitets mønster 
kunne udledes fra VENG. Disse mønstre ændredes mere end 80 s forud for samt under anfald, hvilket 
indikerer at anfald kan detekteres tidligt og monitoreres ved brug af VENG. Detektions metoden er 
specielt velegnet til kontrol af VNS, da stimulation og anfaldsdetektionen kan udføres ved hjælp af den 
samme vagus nerve elektrode. Dog er yderligere studier nødvendige for at fastslå om disse (præ-)iktale 
ændringer er tilstede i andre dyremodeller og i mennesker.  
Inhibition af anfald via elektrisk stimulation er måske ikke eksklusiv relateret til vagus nerven, således 
har stimuleringen af andre neurale strukture og perifere nerver også vist sig at kunne inhibere anfald. Vi 
undersøgte om epidural dorsal stimulation af rygmarven, hvilket er en kendt behandling mod kronisk 
smerte, kunne påvirkede sårbarheden over for anfald. Vores resultater viser at 4 Hz SCS resulterede i en 
klar pro-konvulsiv effekt, hvorimod 54 Hz SCS resulterede i en trend mod en anti-konvulsiv effekt. 
Sårbarheden  over for anfald kan således klar moduleres via SCS, dog er flere studier er nødvendige for at 
evaluere om stimulations parametrene kan optimeres til at inducere en klinisk relevant anfalds inhibition. 
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1. Introduction 
Epilepsy covers a wide range of disorders characterized by a chronic increased seizures predisposition 
and consequently the occurrence of recurrent unprovoked seizures. The seizures are transient events of 
abnormal neural synchronization in the brain, which may affect consciousness and be associated with a 
wide range of motor symptoms (Engel, 2007, Fisher, 2005). Epilepsy occurs as an interplay between both 
genetic predispositions and exposure to risk factors such as infections, head trauma, tumors and stroke 
(Banerjee and Hauser, 2007). With an estimated prevalence of around 1 %, epilepsy is one of the most 
common neurologic disorders in the world (Banerjee and Hauser, 2007, Forsgren et al., 2005, Hauser, 
1996, World Health Organization, 2005).  
Current Treatments 
The preferential treatment for epilepsy is administration of antiepileptic drugs (AED), but only about 2/3 
of patients become seizure free by this means, whereas the others are refractory to medication (Kwan, 
2004). Since the 1980s the development of new drugs has resulted in a two-fold increase of the number of 
available AEDs. However, this abundance of new drugs has primarily helped in reducing the adverse 
effects of the treatment while the fraction of medical refractory patients has remained rather constant 
(Arzimanoglou et al., 2010, Stacey, 2008).  
Up to half of the medical refractory patients may be candidates for resective surgery, which may provide 
long time seizure freedom in more than half of the operated patients. However, it seems that this 
treatment is little used in practice (Beleza, 2009, Engel et al., 2008, Engel, 2003, smith et al., 1989). 
Improvements in diagnostic and surgical techniques continue to increase the fraction of patients, which 
may potentially be treated by surgery, but in some patients no seizure focus can be defined or it may be 
located in structures of essential functional importance and therefore surgery is not an option (Duchowny 
et al., 2008, Jobst, 2009). Patients, who cannot be adequately treated with the described conventional 
means, are candidates for vagus nerve (VN) stimulation (VNS) (Beleza, 2009). Numerous clinical trials 
have shown that this therapy is able to reduce seizure frequency in otherwise intractable epilepsy patients 
by more than 50 % in around half of the treated patients, whom, however, rarely become seizure free (De 
Herdt et al., 2007, DeGiorgio et al., 2000, Labar, 2004, Morris and Mueller, 1999).  
Hence, in spite of the wide range of epilepsy treatments currently available, some patients continue to 
experience inadequate seizure control, which increases the risks of injuries, anxiety, stigmatization, social 
isolation, unemployment and mortality (Baker, 1997, Elliott et al., 2005). Thus, the need for improving 
existing treatments and to explore novel approaches persists.  
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Project goals 
The current work addressed two different areas, which both may facilitate the management of epileptic 
seizures. First, if seizure could be predicted this would render possible a range of new interventions aimed 
to both prevent seizures from occurring and to enable countermeasures to minimize the impact of 
seizures. Research within this area has mainly been focused on predicting seizures based on bioelectric 
signals recorded from the brain. In this project, a novel approach for seizure prediction based on VN 
activity was investigated, as such an approach would be suitable for controlling on-demand VNS. This 
area is introduced in the following section and articles describing this work constitute chapters 2 and 3. 
Second, the ability to inhibit seizures may not be exclusively related to the VN, but stimulation of other 
neural structures may be effective in the treatment of epilepsy too. Research within this area has mainly 
focused on direct stimulation of various brain structures. In the current work, the effect of spinal cord 
stimulation (SCS) on seizure susceptibility is evaluated. SCS is an established treatment for chronic pain 
and peripheral ischemia but received little attention with respect to epilepsy. The background for this 
work is described in section 1.2 and an article describing the work done constitutes chapter 4.  
In Chapter 5, the main findings of this work are discussed and conclusions are given.  
Seizure prediction based on vagus nerve activity 
Seizure prediction 
Prediction of seizures would provide several advantages for epilepsy patients with uncontrolled seizures. 
If seizures could be predicted prior to their electroencephalographic (EEG) and clinical onset, treatment 
procedures could automatically be initiated to prevent them and also, the patient and healthcare personal 
could take countermeasures to minimize the impact of pending seizures.  
Considering such benefits, it is obvious why seizure prediction has been an area for research for more 
than three decades. Nearly all the work done in this area has been aimed at predicting seizures based on 
recordings derived from intracranial EEG (Mormann et al., 2007). Although the initial results of those 
studies seemed promising (Litt, 2002), they looked less encouraging after the availability of larger data 
sets and improved evaluation methods (Mormann et al., 2007). No EEG-based prediction method is yet 
available for treatment of epilepsy.  
Seizures are, however, not manifest in the EEG exclusively: autonomic symptoms such as pupil 
dilatation, skin blushing, respiratory changes and cardiac changes may also occur in relation to seizures 
(Delamont, 1999, Devinsky, 2004, Freeman and Schachter, 1995, Sevcencu and Struijk, 2010, Terndrup 
et al., 1999, Terndrup et al., 1999). Such autonomic changes may provide a source of information to 
assess the ictal state of a patient without the need of intracranial electrodes. The limited work which has 
been done within this area has focused on the discovery of seizure precursors based on changes in the pre-
ictal cardiac control, as they can be derived from the easily obtainable electrocardiogram (ECG). For 
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Fig 1.1 Neuropace system implanted in 
a patient (University of Rochester 
medical center, 2007). 
example, Novak et al. used heart rate variability (HRV) analysis and showed that the parasympathetic 
activity peaks 30 s prior to the onset of complex partial seizures and that sympathetic activity peaks at 
seizure onset. The initial changes observed in that study occurred up to two minutes prior to seizure onset 
(Novak et al., 1999). Similarly, Kerem et al. showed that seizures could be predicted by 30 s to 10 min 
prior to onset using phase space analysis of the RR-interval in epilepsy patients and in a rat model (Kerem 
and Geva, 2005). However, still no ECG based methods for seizure predication are available for clinical 
applications. 
On-demand treatments 
Automated seizure prediction, or at least early detection, 
could enable on-demand treatment to be performed 
primarily during periods with particular need for seizure 
inhibition, thus optimizing the efficiency and minimizing 
the adverse effects of a given treatment. Several forms of 
treatments could be initiated when a seizure is predicted or 
detected. One such treatment could be administration of 
AED directly into the epileptic focus, as this has been 
shown to be effective in animal models (Eder, 1997, Stein, 
2000). Another experimental treatment to arrest ictal 
activity could be the cooling of the neural tissues which 
constitutes the epileptic focus (Rothman, 2009). However, 
the area which so far has received most attention as an on-
demand epilepsy treatment is electrical neurostimulation. One such implantable on-demand 
neurostimulator system ( Neuropace responsive neurostimulator ) has been developed and is being tested 
in clinical trials. The system comprises a stimulator implanted in the scull and two intracranial leads 
through which ictal events are detected and stimulation is performed, see Fig 1.1. Inter-ictal and ictal 
bursts of brain activity are detected using very simple algorithms and electrical stimulation is performed 
in response (Skarpaas and Morrell, 2009, Sun et al., 2008). Long term follow up studies suggest an 
approximately 50 % seizure reduction in 50 % of patients receiving this treatment (Talan, 2010). 
12 
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In contrast with the above mentioned treatments, which are 
still experimental, VNS is already a widely used therapy in 
epilepsy, Fig. 1.2. The VN stimulator can also be triggered 
manually to stimulate prior to or during seizures. VNS is 
provided by a stimulator implanted in a sub-clavicular 
pocket and connected via leads tunneled under the skin to a 
cuff electrode mounted on the left VN. The treatment 
consists of scheduled stimulation typically for 30 s every 5 
min and the induced seizure inhibiting effect tends to slowly 
increase over the first couple of years of treatment (Morris 
and Mueller, 1999). VNS was approved for the treatment of 
epilepsy in the mid-90s in both the EU and the USA. Since 
then, more than 60.000 patients have received an implant 
and nearly 10.000 stimulators are currently sold each year 
(Cyberonics, 2010). 
In addition to this conventional scheduled VNS, stimulation may also be triggered manually by sweeping 
a wrist-worn magnet over the implanted stimulator. The magnet-triggered stimulation lasts typically for 
30 s to 60 s and is usually stronger than scheduled stimulation (Boon et al., 2001, Tatum, 2009). This 
form of control enables patients or caregivers to manually initiate on-demand stimulation on the suspicion 
of an impending seizure or during a seizure. Studies have shown that about half of VNS treated patients 
reported a benefit from this kind of on-demand stimulation, meaning that seizures are fully prevented, 
shortened or alleviated (Boon et al., 2001, Morris, 2003). These studies have, however, relied on the 
ability of patients and caregivers to predict or detect seizures and further to judge if seizure was prevented 
or shortened as a result of triggering VNS. These parameters may be difficult to assess objectively and 
also the task of triggering the stimulator might influence the outcome (Ricci et al., 1972). Indeed, in a 
group of patients where the stimulator was programmed not to stimulate when triggered with the magnet, 
a relatively large percentage (40.7 %) of patients reported a benefit compared to a group which received 
stimulation when using the magnet (52.5 %) (Morris, 2003). A recently developed system designed to 
trigger an implanted VN stimulator in response to external detection of seizures based on EEG and heart 
rate changes in VNS patients, may provide a better indication on how effective on-demand VNS could be 
(Shoeb et al., 2009). However, due to the very limited evaluation of this system in patients, results are 
still inconclusive.   
In addition to studies in patients, several animal experiments also indicate an immediate seizure inhibitory 
effect of VNS. Thus, studies on experimentally induced seizures in rats and dogs have shown that VNS 
could abolish or shorten seizures, especially when initiated prior to or during the start of the seizures 
 
Fig. 1.2 VN stimulator is implanted in 
the a chest pocket and connected to a 
vagus nerve electrode in the neck. 
(The royal childrens’s Hospital 
Melburn, 2009)  
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(McLachlan, 1993, Takaya et al., 1996, Woodbury and Woodbury, 1990, Zabara, 1992). Given the 
immediate seizure inhibiting effect of VNS, the current scheduled form of VNS treatment might be 
improved by stimulating the VN on-demand, that is, prior to and during seizures. Although some patients 
already do this via the magnet-triggered stimulation method, many are incapable of triggering the device, 
either because they cannot operate the magnet, or they do not have any pre-ictal symptoms (i.e., prodrome 
or auras) warning them about oncoming seizures (Boon et al., 2001, Haut, 2007, Morris, 2003, Rajna et 
al., 1997). Thus, if an automated seizure prediction or detection method could be used for on-demand 
VNS, the efficiency of this treatment may increase. If such prediction methods are based on EEG 
recordings, additional cranial leads and electrodes would be required, which would increase the 
complexity of the surgery and increase the risk of complications. This could be avoided if the information 
required for providing on-demand VNS could be retrieved at the site of the implanted VN stimulator. 
Various methods have been suggested for the detection or the prediction of seizures, either to be used 
exclusively or in addition to EEG recordings. These methods include the use of: electrocardiogram 
(ECG), electromyogram (EMG), acceleration (accelerometers in implant) and respiratory activity (Adkins 
et al., 1999, Giftakis and Torgerson, 2010, Giftaktis and Graves, 2007, Lockard et al., 1994). To our 
knowledge, still no clinical systems are available based on these methods. 
The first goal of this study was to develop a new method for the detection or the prediction of seizures 
based on the VN electroneurogram (VENG). As elaborated above, this would be most suitable for on-
demand VNS since it is possible to record with the same VN electrode that is already used for stimulation 
and such an approach would thus not increase the complexity of the implantation procedure. Chapter 2 
and 3 describe the work that was done within this area.  
The effect of spinal cord stimulation on seizure susceptibility 
Currently the only widely used form of electrical neurostimulation treatment of epilepsy is VNS. 
However, the ability to induce seizure inhibition by electrical stimulation may not be related to the VN 
exclusively. Considerable research has evaluated the effect of stimulating several other neural structures. 
Some approaches have directly targeted epileptic foci (Osorio, 2005, Skarpaas and Morrell, 2009), 
whereas others have focused on structures which may contain critical parts of the neural circuits involved 
in ictal activity (Mirski and Fisher, 1994, Mirski et al., 1997). The latter include the thalamus, where 
especially the effect of anterior thalamic stimulation has been evaluated (Fisher, 2010, Jobst, 2009, Mirski 
and Fisher, 1994). Although these intracranial neural stimulation treatments seem to be effective, the 
reduction in seizure frequency is typically similar to that reported with VNS (Ben-Menachem, 2002, 
Fisher, 2010, Talan, 2010), which does not require intracranial surgery. Until intracranial treatments show 
significantly better outcomes regarding seizure inhibition to justify the surgical complexity of the 
methods, it seems unlikely that these treatments will become equal alternatives to VNS.  
14 
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Fig. 1.3 Illustration of a patient with 
an implanted spinal cord stimulator 
(Capitol Spine & Pain Centers, 
2010). 
The mechanisms of action of VNS are not fully known, but its antiepileptic effect seems to be mediated 
by activation of the afferent/sensory fibers in the VN (McLachlan, 1993, Zabara, 1992). Interestingly, 
other forms of sensory stimulation have been reported to prevent seizures. W. R. Gowers described in 
1885 how tactile (touch), olfactory (smell) and gustatory 
(taste) stimulation could abolish pending seizures in his 
patients (Gowers, reprinted 1964).Later studies have 
consistently shown that auditory stimulation could abort 
absence seizures in humans as well (Rajna and Lona, 1989) 
and that tail warming and VNS were equally effective in 
reducing inter-ictal spikes in rats (McLachlan, 1993). More 
recently, DeGiorgio et al. reported that scheduled trigeminal 
nerve stimulation provided via cutaneous electrodes reduced 
seizure frequency by 59 % in medical refractory patients after 
12 months of treatment (DeGiorgio, 2006, DeGiorgio, 2009). 
In contrast, photo, auditory and tactile stimulation have also 
been shown to promote and even to induce seizures (Forster 
and Madow, 1950, Harding and Jeavons, 1994, Manning and 
Uhlrich, 2009). It thus seems that sensory stimulation can exert 
both anti-convulsive and pro-convulsive effects. 
Considering the richness of sensory fibres running through the 
dorsal spinal cord columns (e.g. fasiculus gracilis and fasiculus 
cuneatus), spinal cord stimulation (SCS) might also be a way 
to modulate and inhibit seizure activity without the use of 
intracranial electrodes, see Fig. 1.3. While SCS has been shown to be a safe and effective method for the 
treatment of chronic neuropathic pain, angina pectoris and peripheral and cerebral ischemia (Broseta et 
al., 1986, Cameron, 2004, Murphy and Giles, 1987), the applicability of this therapy in epilepsy has 
received little attention. However, the few reported indirect results on potential antiepileptic effects of 
SCS are encouraging. Thus, a study in patients treated for pain showed that SCS significantly decreased 
the glutamergic mediated cortical excitability and also tended to increase Gamma Aminobutyric Acid 
(GABA) mediated inhibition (Schlaier et al., 2007). Interestingly the later increase in GABA mediated 
inhibition was also shown in epilepsy patients treated with VNS (Di Lazzaro, 2004). In addition, when 
Waltz et al. evaluated SCS as a treatment for spasticity, two patients with concomitant refractory epilepsy 
became seizure free while receiving this therapy (Waltz et al., 1981). The only study we found to directly 
investigate SCS as a treatment for epilepsy suggests that SCS may decrease seizure susceptibility, as the 
frequency of inter-ictal spikes in a rat epilepsy model was reduced by these means (Ozcelik et al., 2007).  
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The second objective of this project was to investigate alternative forms of neurostimulation for the 
treatment of epilepsy. Therefore, and based on the rationale elaborated above, the effect of SCS on 
seizure susceptibility has been evaluated in an experimental study in rats. This work is described in 
chapter 4. 
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5. Discussion, conclusion and perspectives 
In spite of continuous advances within the development of new AEDs and surgical abilities, there still is a 
need for new treatments of epilepsy in general and refractory epilepsy in particular. The goal of this work 
was to investigate new means for improving the management of epilepsy. Two areas were investigated, 
the monitoring and early detection of ictal activity based on activity of the VN, and the effect of SCS on 
seizure susceptibility. 
The experiments related to monitoring and early detection of seizures were carried out in an acute rat 
model of epileptic seizures, where seizures were induced by intravenous infusion of a PTZ solution 
(chapter 2 & 3). The results showed that the left and right VN exhibit distinct cardiac related firing 
patterns in normal conditions (i.e. in control animals and prior to administration of the epileptic agent 
PTZ in the epilepsy group, Fig. 2.3 & 2.4) and that this pattern is altered prior to and during convulsive 
seizures. Cardiac-related changes in the VENG were associated with increased parasympathetic cardiac 
tone. Interestingly, a cardiac-related VENG component which apparently originates from the efferent 
vagal activity persisted/increased in the VENG during seizures in contrast to other components. The 
cardiac-related VENG activity remained altered during the immediate post-ictal period and tended to 
return to baseline activity during the late post-ictal interval, about three minutes after the seizure offset 
(Fig. 2.2 to 2.4). When using the activity derived from the left VENG, it was possible to predict 
convulsive seizures more than 80 s prior to their onset. 
The effect of SCS on seizure susceptibility was evaluated in a rat model where multiple seizures were 
induced by 10 min infusion of a PTZ solution (chapter 4). Dorsal SCS performed at a frequency in the 
typical range used for SCS treatment (54 Hz), did not significantly change any of the parameters used for 
quantifying seizure susceptibility. However, a small trend towards decreased seizure susceptibility was 
induced by 54 Hz SCS. In contrast, 4 Hz SCS induced 4 Hz SW-like ECoG activity and significantly 
increased seizure susceptibility. 
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Fig 5.1 Respiration related VENG power based on 1 
min of baseline recording in a control rat. Increases 
in VENG power is seen prior to and during 
respiration activity. The lowest drops reach around 
50 % indicating that around half of the activity 
recorded is related to respiration. 
Discussion 
Seizure prediction based on vagus nerve activity 
To enable on-demand treatment, seizures must be 
detected and, ideally, predicted. Baseline, pre-ictal, 
ictal and post-ictal VN activity as well as activity in 
controls were studied to explore possibilities of using 
VENG to derive information about the ictal status of 
patients.   
Our results showed that the general vagal activity 
increased significantly during tonic-clonic seizures in 
the PTZ-rat model. This indicates that seizures could 
be detected in this model by monitoring the general 
level of the VENG. However, the increase in the 
general VENG power occurred simultaneous with 
the expansion of the thorax during convulsive 
seizures (KRN 1, Fig 4) and therefore this parameter 
may largely reflect ictal manifestations in the 
respiratory system. Indeed, the cervical vagus nerve 
contains efferent fibers innervating the larynx and 
afferent fibers originating from pulmonary stretch 
receptors. Since all those fibers fire in relation to 
respiration, the respiratory-related VENG power may 
constitute 40 - 60 % of the total VENG activity (unpublished findings, see 5.1). Therefore, changes in the 
respiratory pattern can cause marked changes in the general VENG power. Consistent with this 
observation, Paydarfar and Terndrup reported that the activity of efferent respiratory nerves, including the 
recurrent laryngeal branch of VN, becomes irregular and increases during seizures in cats and pigs 
(Paydarfar et al., 1991, Terndrup et al., 1999). As respiration can be controlled voluntarily and thus may 
be irregular, e.g. during talking, and as the changes in VENG power to a large extent reflect respiratory 
changes, this simple feature may not be specific enough for the prediction/detection and monitoring of 
seizures. 
In contrast to respiration, cardiac function, although subjected to changes according to metabolic 
demands, is under very limited voluntary control and thus might provide more robust features. 
Interestingly, studies have shown that the cardiac control and functions may be affected by seizures, not 
only during the ictal period but also pre-ictally (Kerem and Geva, 2005, Novak et al., 1999, Sevcencu and 
25 
K. R. Harreby 
Struijk, 2010). An indirect way to access the cardiac control is to analyze the variations in the RR-
intervals of the ECG (heart rate variability (HRV) analysis), which can provide an indirect estimate of the 
parasympathetic and sympathetic cardiac tones (Malik, 1996, Novak et al., 1999). Indeed, parameters 
derived from the RR-intervals have been shown to change prior to, during and following seizures 
(Delamont, 1999, Kerem and Geva, 2005, Novak et al., 1999). However, still no such methods are 
available for controlling on-demand treatment. Given that efferent and afferent cardiac fibers are present 
in the VN (Schultz, 2005), it may be expected that information concerning the cardiac parasympathetic 
control and the cardiovascular functions can be derived from the VENG. However, signals related to 
respiratory activity and various other types of visceral activities are also conducted through the vagus 
nerve, which hinders a direct assessment of cardiac control and functions. 
In an attempt to access cardiac-related VENG (CrVENG) selectively, R-peak triggered averaging of the 
VENG activity was performed. This processing method emphasized the activity of those VN fibers that 
are active in phase with the cardiac cycle relative to other VN signals, In this way, the morphology of a 
CrVENG profile can be assessed and information regarding cardiac control can be extracted. 
Our results showed that the left and the right VN exhibit different characteristic firing patterns in relation 
to the cardiac cycle (Fig 2.3 & 2.4). These differences may be due to functional asymmetry of the left vs. 
right vagus nerve (Ardell and Randall, 1986). The firing patterns could be divided into several 
components, C1 - C4. Based on the timing of the CrVENG components and on their correlation with 
parameters derived from the ECG, and based on the physiology of the VN, the physiological origin of the 
CrVENG components was suggested as follows. Activity following the P-wave and prior to the R-peak 
may be related to atrial contraction and ventricular filling, whereas activity following the R-peak may be 
related to the systolic increases in ventricular, coronary and aortic pressure. On the other hand, recordings 
in vagotomized rats showed that vagal firing around 50 ms after the R-peak is related to efferent 
parasympathetic activity, which indicates that the origin of at least parts of C3 is central. This analysis 
does not exclude that other CrVENG components are caused by parasympathetic control too. Further 
research is needed to verify these hypotheses and elucidate the physiological substrates of the CrVENG 
components. 
The CrVENG of both nerves changed significantly during seizures. These changes were manifest as a 
decrease in VENG activity prior to the R-peak and a persistence or increase in the CrVENG components 
occurring after the R-peak. Post-ictally, the ictal firing patterns tended to return towards the pre-ictal 
firing patterns. No significant changes were seen prior to convulsive seizures when analyzing the VENG 
during a fixed 20 s interval just prior to convulsive seizure onset (Fig. 2.4). However, when the CrVENG 
analysis included the whole pre-ictal period in individual animals, detection of seizures was possible more 
than 80 s prior to the onset of the convulsive seizures (Chapter 3 & (Nielsen et al., 2008b) ). 
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The feature configurations which were successfully used in the early detection of seizures (see “X” in Fig. 
3.3) indicated a reduction in CrVENG activity around the R-peak (e.g. C1 in the left nerve, Fig. 2.3) 
relative to activity prior to and after the R-peak. This tendency was related to a general decrease in the 
phasic components of the CrVENG profile prior to seizures (Fig. 3.2c). A similar pattern, although more 
marked, was seen during seizure where the VENG activity occurring during the R-peak was reduced and 
activity following the R-peak actually tended to be increased (Fig. 2.4). These changes in the VN firing 
pattern probably reflect ictal-mediated changes in the parasympathetic cardiac control (i.e. C3 expansion 
in time and amplitude) and changes in cardiovascular functions. Using a pig epilepsy model Terndrup et 
al. showed that the firing of respiratory motor nerves becomes irregular during seizures (Terndrup et al., 
1999). If a similar effect occurs in the cardiac control during seizures (e.g. due to ictal effects on vagal 
cardiac motor neurons), this might result in a reduction of the amplitude of the phasic CrVENG 
components and flattening of this profile, consequently.  
There are some limitations to the presented study. Seizure prediction and detection methods have nearly 
always been based on human data, where e.g. preoperative assessment of patients subjected to epilepsy 
surgery may provide intracranial EEG recordings (Mormann et al., 2007, University Freiburg and the 
University Hospital Freiburg, ). In comparison, VENGs from humans are not available and – considering 
the invasiveness of the methods, acquisition of such recordings during inter-ictal and ictal stages in 
epilepsy patients cannot be justified before clear indications of their usefulness have been provided. Thus, 
our study has been limited to data from an animal model. Our animals were anaesthetized, a state which 
clearly differs from the normal awake state in which a seizure detection/prediction application typically 
will be used. Due to this limitation it was not possible to evaluate if the CrVENG changes we observed 
were specific marker for seizures or if such changes occur due to normal fluctuations in cardiac function 
as well. Moreover, the systemic administration of PTZ involves a risk of direct effects of this drug on 
vagus nerve nuclei or the heart, which are not related to seizures. However, we do however not believe 
this has been the case in our study as the observed cardiac effects were clearly related to the ictal activity 
(Fig. 2.2). Thus, although the PTZ concentration remained constant throughout the recordings due to the 
long half-life of PTZ (2 hours in rats (Ramzan and Levy, 1985)), all the acquired parameters reverted  
during the post-ictal periods. Nevertheless, extrapolating the results from chemical induced seizures in 
animals to chronic epilepsy in human patients should be made with caution, as the mechanism supporting 
the seizure onset in these two situations may differ (Fisher, 1989). In addition, the different types of 
seizures and even the individual seizures in one and the same patient may also result in different cardiac 
manifestations (Sevcencu and Struijk, 2010).  
Finally, to ensure similar pre-ictal conditions, the analysis for early detection of seizures (chapter 3) was 
restricted to only one pre-ictal period starting from baseline (prior to PTZ administration). Thus, the 
optimization of the detection method could only be performed across rats and not within each individual 
27 
K. R. Harreby 
animal. In addition, optimization and detection was performed on the same set of recordings and no 
dedicated test data was used. However, the results showed that a range of similar feature settings would 
enable the early detection of seizures, and therefore we do not believe that the lack of the test data has 
significantly affected the conclusions drawn from this study. Meanwhile, it is obvious that further 
research is needed to investigate if the observed pre-ictal effects would also occur in other animal models 
of seizures and if the identified features can be optimized to individual subjects (see “Further research”).  
The effect of spinal cord stimulation on seizure susceptibility  
Various findings have shown that sensory stimulation affect seizure susceptibility (DeGiorgio, 2009, 
Forster and Madow, 1950, Gowers, reprinted 1964, Harding and Jeavons, 1994, Manning and Uhlrich, 
2009, McLachlan, 1993, Rajna and Lona, 1989). These observations and the fact that the dorsal spinal 
cord columns are abundant in sensory fibres, suggest that SCS may also interfere with seizure 
susceptibility and thus be used for the treatment of epilepsy. SCS has been shown to be a safe and well 
tolerated treatment of pain and peripheral ischemia, thus the therapy could easily be extended to epilepsy 
patients too. As SCS has received little attention within the area of epilepsy, we aimed to investigate if 
seizure susceptibility could be modulated by SCS. For evaluating the effect of SCS on seizure 
susceptibility, the PTZ seizure model that we developed in anesthetized rats seems very suitable. Hence, 
various types of epilepsy treatments have been tested in the PTZ models including VNS, trigeminal nerve 
stimulation, anterior thalamic stimulation and antiepileptic drugs therapies. The results of those studies 
have later been shown to extrapolate well to patients (Ben-Menachem, 2002, DeGiorgio, 2009, Fanselow 
et al., 2000, Mirski et al., 1997, White, 1995, Woodbury and Woodbury, 1990) 
In the present work, the animals were randomly separated in three experimental groups. One group acted 
as controls and did not receive any stimulation. A second group received SCS at a frequency, similar to 
the frequency of typical spike-wave discharges in absence seizures (4 Hz), which was considered as 
potentially pro-convulsive.  Finally, a third group received 54 Hz SCS, which is similar to the frequency 
typically used in SCS treatments in patients (Gao et al., 2010). The latter frequency was hypothesised to 
be anti-convulsive as reduced cortical excitability was demonstrated in SCS patients treated for pain 
(Schlaier et al., 2007).  
The results of this study showed that 4 Hz stimulation induced large spike-wave like ECoG complexes in 
a 1:1 manner, even prior to the administration of the pro-convulsive drug, PTZ. This relation was 
interrupted only during convulsive seizures characterized by around 10 Hz cortical spikes and during the 
post-ictal periods where ECoG suppression occurred. In a study on cats, Gutnick et al. observed a 
phenomenon which may explain the absence of cortical effects of 4 Hz SCS during convulsive seizures. 
These authors reported that experimentally induced cortical spikes cause an inhibition of the afferent 
thalamic transmission for up to approximately 200 ms following the cortical spikes (Gutnick and Prince, 
1974). This indicates that the ictal cortical spikes occurring at frequencies above 5 Hz may progressively 
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inhibit the supraspinal effects of SCS by blocking their thalamic transmission, which suggests that seizure 
susceptibility may be modulated by SCS only pre-ictally. When the convulsive cortical activity is already 
present in the form of high frequency discharges, the central effects of SCS may thus be hampered.  
Low frequency stimulation at supra motor threshold has been suggested as a mean for correct positioning 
of the spinal cord electrode during implantation. In addition, low frequency (4 – 25 Hz) SCS seems to be 
effective in the treatment of pain in humans (33) and hyperalgesia in rats (34). As our results indicate that 
such low frequencies may induce a pro-convulsive effect, further research should clarify if this may also 
be an issue in humans e.g. by evaluating if cortical synchronization occurs when using low frequency for 
the positioning of the stimulation electrode. 
 
In contrast to our results, Ozcelik et al. indicated that low frequency SCS at 2 Hz reduced seizure 
susceptibility, as the frequency of cortical spikes were decreased by this means in a rat model (Ozcelik et 
al., 2007). The discrepancy between those and our results may be related to the different stimulation 
intensity, i.e. up to 0.1 mA used by Ozelik et al. and approximately 0.3 mA applied in our study. Thus, 
the higher currents that we used for SCS may have been able to activate enough dorsal column fibres to 
induce a potentially pro-convulsive thalamocortical synchronisation, whereas the 0.1 mA pulses used by 
Ozelik et al may have been too weak to cause a similar effect, but strong enough to interfere with the 
spontaneous spiking activity. This explanation is in accordance with the results of Hamani et al., who 
observed that the effect of the anterior thalamic stimulation depends on the stimulation intensity and is 
anti-convulsive, when using 0.5 mA pulses and pro-convulsive when increasing the stimulation current to 
1.0 mA (Hamani et al., 2008).  
In our study, 54 Hz SCS caused a small evoked cortical potential at the onset of stimulation, but no 
further changes in the ECoG activity. Stimulation at this frequency resulted in decreased seizure 
susceptibility in all evaluated parameters and the only animal to display only one seizure was from this 
group. However, these effects were not statistically significant. 
The pro-convulsive effect induced by 4 Hz stimulation clearly shows that seizure susceptibility can be 
modulated by SCS. In addition, although below statistical and clinical significance levels, the anti-
convulsive effects induced by 54 Hz stimulation suggest that SCS may have the ability to reduce seizure 
susceptibility. Thus, further research is needed to evaluate if the stimulation parameters can be optimized 
to induce a statistically significant and clinically relevant reduction in seizure susceptibility. As our 
experiments and the reports of others (e.g. Hamani et al., 2008) indicate that the effect of SCS on seizures 
may depend on both frequency and intensity of stimulation, both parameters should be analysed in future 
studies.  
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Conclusion  
In the first part of this study, a specific cardiac-related firing pattern could be derived from VENG 
recordings in anesthetized rats. As these firing patterns change prior to and during seizures, the VENG 
may provide a source of information for prediction, detection and monitoring of seizures. Such VN-based 
methods may be especially suitable for controlling VNS in epilepsy patients, as stimulation and recording 
can be performed with one and the same electrode. Further research is needed to investigate if the method 
is applicable in awake animals and with human size VNs before such methods can be evaluated in 
humans.  
The second part of this study showed that low frequency SCS significantly increases seizure 
susceptibility, whereas 54 Hz SCS resulted in a trend towards inhibition of seizures. Thus, SCS is clearly 
capable of modulating seizure susceptibility. Further research is needed to investigate if stimulation 
parameters can be optimized to inhibit seizures.  
Perspectives 
Both the areas investigated in the presented work require more research before clinical applications can 
be derived.  
Seizure prediction based on vagus nerve activity 
Seizure detection/prediction based on VENG analysis, should ideally be investigated further in a chronic 
epilepsy model with VN and cardiorespiratory characteristics similar to those of humans during awake 
and unrestrained conditions. However, this would require a lot of resources in the development of a 
(partly) implantable system for recording VENG. Thus, a more incremental approach could be to transfer 
the methods established in rats to an acute pig model, which is closer to humans regarding the anatomy of 
the cardiorespiratory system and the VN. To enable feature optimization in individual animals and proper 
evaluation of the applied seizure prediction/detection method (e.g. by comparing against a random 
predictor (Andrzejak, 2003)), longer recordings and several seizure are required from each animal. 
Another step could be to record VENG in patients during VNS implantation (e.g. via the stimulation 
electrode or a hook electrode), to investigate if a CrVENG profile can be derived from the human VNs 
during baseline / inter-ictal state. 
The general idea of predicting/detecting seizures based on VENG is that information retrieved close to the 
implanted stimulator device could be used for enabling on-demand VNS treatment. Our results show that 
the CrVENG carries information which might be used for prediction and detection of seizures. However, 
seizure prediction/detection should not rely on one feature only. Information derived from multiple 
features may be combined to increase sensitivity and specificity. Some of these additional features might 
also be derived from the VENG, such as the VENG energy. However, features may also be derived from 
other types of inputs available at the site of the implant such as: ECG, EMG, Respiration (nerve recording 
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/ impedance), device movement (accelerometers), device orientation (accelerometers) ect. (Feldwisch-
Drentrup, 2010, Giftaktis and Graves, 2007, Lockard et al., 1994). Information derived from 
accelerometers may e.g. help to differentiate if cardiac or respiratory changes are due to physical activity 
or ictal activity.  
The required sensitivity and specificity will depend on different aspects, such as the consequences of a 
false detected seizure and missed seizures (Litt, 2003). The consequences of initiating VNS due to a false 
seizure prediction does not seem to have serious adverse effects, given that epilepsy patients currently 
receive scheduled stimulation. In fact, it may be advantages to provide a level of scheduled VNS in 
addition to on-demand stimulation, to ensure the induction of the slowly (over several months) 
accumulating seizure inhibition. However, if patients associate the onset of stimulation with an increased 
risk of having an imminent seizure, too many false predictions may cause unnecessary anxiety. 
One of the challenges for a VENG based seizure detection method is to record the low amplitude nerve 
signal (µV) in the presences movement and noise from the surrounding muscle and heart activity (mV) 
(Hoffer and Kallesøe, 2001). In addition, chronic implanted cuff electrodes may be subject to ingrowth of 
connective tissue which may over time shield the electrode contacts from the nerve fibers, thus decreasing 
the signal amplitude. The use of synchronized averaging of the VENG signal makes the developed 
CrVENG-based detection method more robust to such deterioration of the VENG. However, further 
research should access VENG under awake conditions and also investigate the possibility of recording 
VN activity over longer periods of time to evaluate the effect of encapsulation on VENG signal to noise 
ratio, and the ability to predict/detect seizures under such conditions.  
Seizure prediction/detection methods based on VENG will require further animal tests in both acute and 
chronic animal experiments before they can be evaluated in human patients. In addition, the hardware: a 
cuff electrode capable of both recording and stimulating, and an implantable device capable of acquiring 
VENG, signal processing and stimulation will need to be developed. Thus, if further research proves 
VENG based prediction/detection methods are effective, it may still take 5-10 years before clinical 
applications can be available.  
 
The effect of spinal cord stimulation on seizure susceptibility 
Regarding the further assessment of the effect of SCS on seizure susceptibility, a range of stimulation 
parameters needs to be evaluated. A method might be to evaluate the ability of different stimulation 
parameters to attenuate spike-wave activity (McLachlan, 1993, Ozcelik et al. 2007) in a PTZ model. 
Although this is an indirect method of evaluating the effect of SCS on seizure susceptibility, it enables the 
evaluation of many different stimulation parameters in each animal. The stimulation parameters most 
effective in inducing cortical desynchronization could later be tested in their ability to inhibit actual 
seizures in a cross over study (Takaya et al., 1996). In addition to animal studies, the effect of SCS in e.g. 
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pain patients with concomitant epilepsy may be accessed in a systematic way. However, it may be a 
difficult to find a sufficient number of such patients and variations between patients regarding epilepsy 
disorders and the SCS paradigm applied (spinal level of stimulation, duration of stimulation per day, 
stimulation frequency, stimulation current ect.) may also prove such a study problematic.   
Given that SCS paradigms to inhibit seizures are developed, it will be of great benefit for the acceptance 
of the treatment that SCS is already widely used for other disorders. Thus, the technology and clinical 
expertise is already present within this area. A problem for many types of epilepsy treatments and in 
particular those involving invasive surgery, is that eventually a treatment will only be beneficially for a 
fraction of the treated patients e.g. only around half of VNS treated patients will become responders 
(>50% seizure reduction)   (De Herdt et al., 2007, DeGiorgio et al., 2000, Labar, 2004, Morris and 
Mueller, 1999). If non-responders could be excluded prior to implantation, they would not need to be 
exposed to the risk of surgery, adverse effects of the treatment and also cost could be reduced. An 
approach is to evaluate the effect of the treatment in patients in a minimal invasive way prior to the actual 
implantation. This may be possible with dorsal SCS, as the effect of stimulation can be tested with 
transcutaneous electrodes and an external stimulator before implanting a permanent spinal electrode and 
stimulator (Kunnumpurath et al., 2009, North, 2007). 
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